Showing results (1241-1250 of 1,708) with videos related to

Sort By:
Pageof 171
The Journal of Thoracic and Cardiovascular Surgery|July 12, 2022
Coronary artery bypass grafting versus medical therapy in patients with stable coronary artery disease: An individual patient data pooled meta-analysis of randomized trialsMario Gaudino, Katia Audisio, Whady A Hueb, et al.
Circulation. Cardiovascular Interventions|August 7, 2014
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registryAkshay Bagai, Yongfei Wang, Tracy Y Wang, et al.
Journal of the American Heart Association|May 27, 2022
Cangrelor Use Patterns and Transition to Oral P2Y<sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO RegistryJennifer A Rymer, Deepak L Bhatt, Dominick J Angiolillo, et al.
JAMA Cardiology|April 7, 2024
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical TrialAlexander Peikert, Brian L Claggett, Jacob A Udell, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 4, 2024
One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trialSigrid Sandner, Mario Gaudino, Bjorn Redfors, et al.
European Journal of Preventive Cardiology|March 31, 2026
Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 StudyMichael Szarek, Lawrence A Leiter, Hwee Teoh, et al.
American Heart Journal|October 30, 2020
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysisAnubodh S Varshney, David E Wang, Ankeet S Bhatt, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
JAMA|November 5, 2014
Nonobstructive coronary artery disease and risk of myocardial infarctionThomas M Maddox, Maggie A Stanislawski, Gary K Grunwald, et al.
Circulation|August 28, 2022
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial InfarctionSunil V Rao, Bodo Kirsch, Deepak L Bhatt, et al.
Pageof 171